Subject:Firstname Lastname - New Position I am pleased to announce the promotion of [Firstname Lastname] from [Old Position] to [New Position]. [Firstname] has been with [Name of Company] for [X years] and has worked in [insert Names of Departments/Positions]. [Firstname] attended [...
risks related to the ability of Intellia’s licensors to protect and maintain their intellectual property position; uncertainties related to the development of the company’s product candidates, including product candidates to be developed in its collaboration with ReCode, and the authorization,...
LinkedIn Facebook Email Print Clinical researchPhase IIIAsiaEurope MORE ON THIS TOPIC Layoffs Compass Delays Pivotal Trial Readouts for Psilocybin in Depression, Lays Off 30% of Staff October 31, 2024 · 2 min read · Heather...
If you’re in a position to open a new location for your established business, that’s a good sign for the long term prospects of your operations. Of course without the support of existing customers, getting the word out and gaining momentum will be harder. Here are some ways...
Harry speaks from a position of experience. He admits to having been a heavy Twitter user. As a teenager, he spent up to 16 hours a day on the platform. "Unbelievably unhealthy now I look back at it," he confesses with remorse. ...
Twitter LinkedIn Facebook Email Print Europe Alvotech MORE ON THIS TOPIC Radiopharmaceuticals Sanofi Inks $326M Radiopharma Deal With Orano October 17, 2024 · 2 min read · Tristan Manalac Obesity Lilly’s Sprawling Obesity Clinical Program Underscores Challenges for Biotechs ...
Mumbai, New York, September 06, 2021 : Non-profit drug developer, TB Alliance has granted global pharma major Lupin Limited (Lupin), a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug “BPaL” regimen. Lupin inte
Moderna, Inc. (NASDAQ: MRNA) today announced a long-term agreement with Ontario-based Novocol Pharma, a leading sterile injectable contract development and manufacturing organization (CDMO), to perform aseptic fill-finish, labelling and packaging of mRNA
“New GMIN”) and the latter’s future outlook and that of its affiliates when applicable; and to anticipated events or results, notably the transaction completion, as contemplated; and may include statements regarding the financial position, budgets, operations, financial results, plans and ...
Twitter LinkedIn Facebook Email Print AlliancesAcademiaEurope Ipsen Biopharmaceuticals, Inc. MORE ON THIS TOPIC Policy GSK Quits Trade Group BIO as Industry Faces Uncertain Political Future November 11, 2024 · 2 min read · Tristan Manalac